Biotech

Researchers at the University of Washington's Institute for Protein Design have designed protein-cutting enzymes from scratch, and report that 13 of the 69 designs work, including inside living…

A research group at Sichuan University has built an RNA imaging system for plants in which the fluorescent probe is destroyed unless it is bound to its target, and used it to follow single messenger…

A Google DeepMind team has hidden a mark inside proteins designed by artificial intelligence, so that the molecule itself shows a machine made it. The system, called SynthIDBio, appeared in Nature on…

Anthropic said on Sept. 23 that it has opened a life sciences research group and laboratory, and published a first result from it: an enzyme system found in viruses that infect bacteria, picked out…

Beacon Therapeutics said on Sept. 21 that its experimental gene therapy for X-linked retinitis pigmentosa, an inherited eye disease with no approved treatment, met the main goal of a controlled trial…

The FDA approved Fayuvi (rebisufligene etisparvovec-hopf) on Sept. 17, 2026, making it the first treatment designed to alter the course of mucopolysaccharidosis type IIIA (MPS IIIA), a rare inherited…

Focused ultrasound aimed at the heart from outside the body raised the heart rate of mice without surgery and without a drug, a team at ShanghaiTech University in Shanghai reports in the journal…

The U.S. Food and Drug Administration has told Biohaven to stop enrolling new patients in its late-stage trials of the epilepsy drug BHV-7000, according to a filing by the company. The hold applies…

Google DeepMind released AlphaGenome Atlas on Sept. 8, a database of predicted molecular effects for 9 billion single-letter DNA changes (every one possible in the human genome) free to academic…

Six computer models that estimate a person's age from proteins in the blood were run over blood samples from the same 42-patient drug trial, and all six scored the treated patients younger. Insilico…

The Food and Drug Administration approved Zanvastro (zilganersen) injection on Sept. 3 for Alexander disease, a rare inherited disorder of the nervous system, and says it is the first approved…

The Hong Kong-listed drug developer Akeso said on Sept. 2 that its lung-cancer antibody ivonescimab met the overall-survival endpoint of a Phase III trial that tested it against pembrolizumab, and…